Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.89 | 1.97 | 0.08 |
Stocks | 98.10 | 98.10 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.92 | 21.72 |
Price to Book | 5.22 | 4.01 |
Price to Sales | 2.33 | 2.28 |
Price to Cash Flow | 19.60 | 16.97 |
Dividend Yield | 1.20 | 1.34 |
5 Years Earnings Growth | 11.94 | 11.14 |
Number of long holdings: 50
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.05 | 755.91 | -2.68% | |
UnitedHealth | US91324P1021 | 7.27 | 492.97 | +1.83% | |
Novo Nordisk B | DK0062498333 | 7.11 | 873.1 | -2.74% | |
Merck&Co | US58933Y1055 | 5.69 | 128.26 | -0.42% | |
Thermo Fisher Scientific | US8835561023 | 4.51 | 571.25 | -0.65% | |
AstraZeneca | GB0009895292 | 3.68 | 12,156.0 | -0.12% | |
Abbott Labs | US0028241000 | 3.66 | 105.92 | -0.35% | |
Roche Holding Participation | CH0012032048 | 2.84 | 214.10 | -2.95% | |
Sanofi | FR0000120578 | 2.82 | 91.90 | -1.27% | |
Boston Scientific | US1011371077 | 2.70 | 72.03 | -0.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 820.4M | 5.85 | 7.83 | 19.37 | ||
AXA Framlington Global Technology F | 148.22M | 5.85 | 7.83 | 19.36 | ||
GB00B5LXGG05 | 689.55M | 9.93 | 12.94 | 16.96 | ||
AXA Framlington UK Mid Cap Fund S I | 7.93M | -1.30 | -3.05 | 4.46 | ||
AXA Framlington UK Mid Cap Z Acc | 161.54M | 4.03 | -2.40 | 4.67 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review